Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Money is beginning to shift away from stocks that did well while the economy shut down to fight coronavirus. The shifts have picked up since Moderna announced impressive data from a Phase 1 trial for a vaccine against coronavirus. Now investors should look ahead to the post-vaccine world: Sell stocks that are
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
For investors trying to navigate this stock market, not enough is known about the coronavirus. There is a divergence of opinions on almost all points. The result is an environment in the market that is creating both perils and opportunities. Many important pieces of data that affect the stock market
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
In the wake of coronavirus-related volatility in the stock market, investors are asking: “Is the economic data showing that there will be a depression?” The No. 1 mistake investors make as they try to figure out the answer is that they are mostly focused on one dimension of a two-dimensional